Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 92 Projects
Project # Contact PI Funding Organization Fiscal Year
Validation of the Retinal Deep Phenotyping (TM) platform for the detection of the likely cerebral amyloid status to aid in the diagnosis of Alzheimer's disease
ADDF-31 Sylvestre, Jean-Philippe Alzheimer's Drug Discovery Foundation 2021
Measurement of immune cell recruitment as a biomarker of neuroinflammation in Alzheimer's disease and other diseases of the central nervous system
ADDF-32 Menniti, Frank Alzheimer's Drug Discovery Foundation 2021
Evaluating the effects of GLP-1 analog, oral semaglutide, as a treatment for sporadic behavioral variant frontotemporal dementia (bvFTD)
ADDF-33 Edison, Paul Alzheimer's Drug Discovery Foundation 2021
Open-label Clinical Trial of Nabilone for Neuropsychiatric Symptoms in Frontotemporal Dementia
ADDF-34 Ducharme, Simon Alzheimer's Drug Discovery Foundation 2021
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
ADDF-35 Panzara, Michael Alzheimer's Drug Discovery Foundation 2021
Plasma pathologic TDP-43 as a biomarker for FTLD-TDP
ADDF-36 Mao, Qinwen Alzheimer's Drug Discovery Foundation 2021
Can Lifestyle Changes Stop or Reverse the Progression of MCI Due to Early-Stage Alzheimer's Disease?
ADDF-37 Ornish, Dean Alzheimer's Drug Discovery Foundation 2021
Easy and early plasma pTau181 detection with LUMIPULSE G platform as indicator of Alzheimer's disease
ADDF-38 Vandijck, Manu Alzheimer's Drug Discovery Foundation 2021
Effects of Chaperone-Mediated Autophagy in Alzheimer's Disease
ADDF-39 Cermak, Jennifer Alzheimer's Drug Discovery Foundation 2021
Clinical Trials for Alzheimer's Disease CTAD
ADDF-40 Touchon, Nathanaelle Alzheimer's Drug Discovery Foundation 2021